Adipose Tissue Derived Stem Cell - Global and China Top Players Market Share and Ranking 2023
According to YH Research, the global market for Adipose Tissue Derived Stem Cell should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China Adipose Tissue Derived Stem Cell market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Adipose Tissue Derived Stem Cell market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Regenerative Medicine grew percent to account for percent of the total market sales, and Plastic Surgery grew percent.
The stem cells from adipose tissue have a variety of uses, including research on stem cell differentiation, cell therapy, tissue engineering, and the creation of induced pluripotent stem cell lineages. These are rich in multipotent stem cells, adipocytes, osteocytes, chondrocytes, and other cell types can all be differentiated into adipocytes, osteocytes, and other cell types in vitro.
This report studies and analyses global Adipose Tissue Derived Stem Cell status and future trends, helps the client to determine the Adipose Tissue Derived Stem Cell market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Adipose Tissue Derived Stem Cell, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Adipose Tissue Derived Stem Cell market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Adipose Tissue Derived Stem Cell sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Adipose Tissue Derived Stem Cell sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Adipose Tissue Derived Stem Cell key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Adipose Tissue Derived Stem Cell key producing regions, capacity, production, and year over year growth
(6) Adipose Tissue Derived Stem Cell industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Lonza
ThermoFisher Scientific Inc
Celprogen, Inc
iXCells Biotechnologies
Merck KGaA
Lifeline Cell Technology
AlloCure, Inc
Antria, Inc
Celgene Corporation
Cellleris SA
Corestem, Inc
Cytori Therapeutics, Inc
Intrexon, Inc
Mesoblast Ltd
Pluristem Therapeutics, Inc
Tissue Genesis
Market segment by Type, covers
Source of Human Fat
Source of Animal Fat
Market segment by Application, can be divided into
Regenerative Medicine
Plastic Surgery
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Adipose Tissue Derived Stem Cell product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Adipose Tissue Derived Stem Cell market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Adipose Tissue Derived Stem Cell market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Adipose Tissue Derived Stem Cell, percent & CAGR, 2018-2029
Chapter 5: Adipose Tissue Derived Stem Cell industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Adipose Tissue Derived Stem Cell Definition
1.2 Global Adipose Tissue Derived Stem Cell Market Size and Forecast
1.2.1 By Consumption Value, Global Adipose Tissue Derived Stem Cell Market Size，2018-2029
1.2.2 By Sales Quantity, Global Adipose Tissue Derived Stem Cell Market Size，2018-2029
1.2.3 Global Adipose Tissue Derived Stem Cell Average Selling Price (ASP)，2018-2029
1.3 China Adipose Tissue Derived Stem Cell Market Size and Forecast
1.3.1 By Consumption Value, China Adipose Tissue Derived Stem Cell Market Size，2018-2029
1.3.2 By Sales Quantity, China Adipose Tissue Derived Stem Cell Market Size，2018-2029
1.3.3 China Adipose Tissue Derived Stem Cell Average Selling Price (ASP)， 2018-2029
1.4 Share of China Adipose Tissue Derived Stem Cell Market with Respect to the Global Market
1.4.1 By Consumption Value, China Adipose Tissue Derived Stem Cell Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Adipose Tissue Derived Stem Cell Market Share in Global, 2018-2029
1.4.3 Adipose Tissue Derived Stem Cell Market Size: China VS Global, 2018-2029
1.5 Adipose Tissue Derived Stem Cell Market Dynamics
1.5.1 Adipose Tissue Derived Stem Cell Market Drivers
1.5.2 Adipose Tissue Derived Stem Cell Market Restraints
1.5.3 Adipose Tissue Derived Stem Cell Industry Trends
1.5.4 Adipose Tissue Derived Stem Cell Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Adipose Tissue Derived Stem Cell, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Adipose Tissue Derived Stem Cell, Global Market Share by Company, 2018-2023
2.3 Adipose Tissue Derived Stem Cell Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Adipose Tissue Derived Stem Cell Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Adipose Tissue Derived Stem Cell Concentration Ratio
2.6 Global Adipose Tissue Derived Stem Cell Mergers & Acquisitions, Expansion Plans
2.7 Global Adipose Tissue Derived Stem Cell Manufacturers Product Type
2.8 Head Office and Adipose Tissue Derived Stem Cell Production Site of Key Manufacturer
2.9 Adipose Tissue Derived Stem Cell Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Adipose Tissue Derived Stem Cell, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Adipose Tissue Derived Stem Cell, China Market Share by Company, 2018-2023
3.3 China Adipose Tissue Derived Stem Cell Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Adipose Tissue Derived Stem Cell Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Adipose Tissue Derived Stem Cell Capacity by Region
4.3 Global Adipose Tissue Derived Stem Cell Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Adipose Tissue Derived Stem Cell Production by Region, 2018-2029
4.5 Global Adipose Tissue Derived Stem Cell Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Adipose Tissue Derived Stem Cell Industry Chain
5.2 Adipose Tissue Derived Stem Cell Upstream Analysis
5.2.1 Adipose Tissue Derived Stem Cell Core Raw Materials
5.2.2 Main Manufacturers of Adipose Tissue Derived Stem Cell Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Adipose Tissue Derived Stem Cell Production Mode
5.6 Adipose Tissue Derived Stem Cell Procurement Model
5.7 Adipose Tissue Derived Stem Cell Industry Sales Model and Sales Channels
5.7.1 Adipose Tissue Derived Stem Cell Sales Model
5.7.2 Adipose Tissue Derived Stem Cell Typical Distributors
6 Sights by Type
6.1 Adipose Tissue Derived Stem Cell Classification
6.1.1 Source of Human Fat
6.1.2 Source of Animal Fat
6.2 By Type, Global Adipose Tissue Derived Stem Cell Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Adipose Tissue Derived Stem Cell Consumption Value, 2018-2029
6.4 By Type, Global Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029
6.5 By Type, Global Adipose Tissue Derived Stem Cell Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Adipose Tissue Derived Stem Cell Segment by Application
7.1.1 Regenerative Medicine
7.1.2 Plastic Surgery
7.1.3 Other
7.2 By Application, Global Adipose Tissue Derived Stem Cell Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Adipose Tissue Derived Stem Cell Consumption Value, 2018-2029
7.4 By Application, Global Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029
7.5 By Application, Global Adipose Tissue Derived Stem Cell Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Adipose Tissue Derived Stem Cell Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Adipose Tissue Derived Stem Cell Consumption Value, 2018-2029
8.3 By Region, Global Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Adipose Tissue Derived Stem Cell & Forecasts, 2018-2029
8.4.2 By Country, North America Adipose Tissue Derived Stem Cell Market Size Market Share
8.5 Europe
8.5.1 Europe Adipose Tissue Derived Stem Cell Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Adipose Tissue Derived Stem Cell Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Adipose Tissue Derived Stem Cell Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Adipose Tissue Derived Stem Cell Market Size Market Share
8.7 South America
8.7.1 South America Adipose Tissue Derived Stem Cell Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Adipose Tissue Derived Stem Cell Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Adipose Tissue Derived Stem Cell Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Adipose Tissue Derived Stem Cell Consumption Value, 2018-2029
9.3 By Country, Global Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Adipose Tissue Derived Stem Cell Market Size, 2018-2029
9.4.2 By Type, U.S. Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Adipose Tissue Derived Stem Cell Market Size, 2018-2029
9.5.2 By Type, Europe Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Adipose Tissue Derived Stem Cell Market Size, 2018-2029
9.6.2 By Type, China Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Adipose Tissue Derived Stem Cell Market Size, 2018-2029
9.7.2 By Type, Japan Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Adipose Tissue Derived Stem Cell Market Size, 2018-2029
9.8.2 By Type, South Korea Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Adipose Tissue Derived Stem Cell Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Adipose Tissue Derived Stem Cell Market Size, 2018-2029
9.10.2 By Type, India Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Adipose Tissue Derived Stem Cell Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Lonza
10.1.1 Lonza Company Information, Head Office, Market Area, and Industry Position
10.1.2 Lonza Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.1.3 Lonza Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Lonza Company Profile and Main Business
10.1.5 Lonza Recent Developments
10.2 ThermoFisher Scientific Inc
10.2.1 ThermoFisher Scientific Inc Company Information, Head Office, Market Area, and Industry Position
10.2.2 ThermoFisher Scientific Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.2.3 ThermoFisher Scientific Inc Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 ThermoFisher Scientific Inc Company Profile and Main Business
10.2.5 ThermoFisher Scientific Inc Recent Developments
10.3 Celprogen, Inc
10.3.1 Celprogen, Inc Company Information, Head Office, Market Area, and Industry Position
10.3.2 Celprogen, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.3.3 Celprogen, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Celprogen, Inc Company Profile and Main Business
10.3.5 Celprogen, Inc Recent Developments
10.4 iXCells Biotechnologies
10.4.1 iXCells Biotechnologies Company Information, Head Office, Market Area, and Industry Position
10.4.2 iXCells Biotechnologies Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.4.3 iXCells Biotechnologies Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 iXCells Biotechnologies Company Profile and Main Business
10.4.5 iXCells Biotechnologies Recent Developments
10.5 Merck KGaA
10.5.1 Merck KGaA Company Information, Head Office, Market Area, and Industry Position
10.5.2 Merck KGaA Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.5.3 Merck KGaA Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Merck KGaA Company Profile and Main Business
10.5.5 Merck KGaA Recent Developments
10.6 Lifeline Cell Technology
10.6.1 Lifeline Cell Technology Company Information, Head Office, Market Area, and Industry Position
10.6.2 Lifeline Cell Technology Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.6.3 Lifeline Cell Technology Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Lifeline Cell Technology Company Profile and Main Business
10.6.5 Lifeline Cell Technology Recent Developments
10.7 AlloCure, Inc
10.7.1 AlloCure, Inc Company Information, Head Office, Market Area, and Industry Position
10.7.2 AlloCure, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.7.3 AlloCure, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 AlloCure, Inc Company Profile and Main Business
10.7.5 AlloCure, Inc Recent Developments
10.8 Antria, Inc
10.8.1 Antria, Inc Company Information, Head Office, Market Area, and Industry Position
10.8.2 Antria, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.8.3 Antria, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Antria, Inc Company Profile and Main Business
10.8.5 Antria, Inc Recent Developments
10.9 Celgene Corporation
10.9.1 Celgene Corporation Company Information, Head Office, Market Area, and Industry Position
10.9.2 Celgene Corporation Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.9.3 Celgene Corporation Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Celgene Corporation Company Profile and Main Business
10.9.5 Celgene Corporation Recent Developments
10.10 Cellleris SA
10.10.1 Cellleris SA Company Information, Head Office, Market Area, and Industry Position
10.10.2 Cellleris SA Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.10.3 Cellleris SA Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Cellleris SA Company Profile and Main Business
10.10.5 Cellleris SA Recent Developments
10.11 Corestem, Inc
10.11.1 Corestem, Inc Company Information, Head Office, Market Area, and Industry Position
10.11.2 Corestem, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.11.3 Corestem, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Corestem, Inc Company Profile and Main Business
10.11.5 Corestem, Inc Recent Developments
10.12 Cytori Therapeutics, Inc
10.12.1 Cytori Therapeutics, Inc Company Information, Head Office, Market Area, and Industry Position
10.12.2 Cytori Therapeutics, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.12.3 Cytori Therapeutics, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Cytori Therapeutics, Inc Company Profile and Main Business
10.12.5 Cytori Therapeutics, Inc Recent Developments
10.13 Intrexon, Inc
10.13.1 Intrexon, Inc Company Information, Head Office, Market Area, and Industry Position
10.13.2 Intrexon, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.13.3 Intrexon, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Intrexon, Inc Company Profile and Main Business
10.13.5 Intrexon, Inc Recent Developments
10.14 Mesoblast Ltd
10.14.1 Mesoblast Ltd Company Information, Head Office, Market Area, and Industry Position
10.14.2 Mesoblast Ltd Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.14.3 Mesoblast Ltd Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Mesoblast Ltd Company Profile and Main Business
10.14.5 Mesoblast Ltd Recent Developments
10.15 Pluristem Therapeutics, Inc
10.15.1 Pluristem Therapeutics, Inc Company Information, Head Office, Market Area, and Industry Position
10.15.2 Pluristem Therapeutics, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.15.3 Pluristem Therapeutics, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Pluristem Therapeutics, Inc Company Profile and Main Business
10.15.5 Pluristem Therapeutics, Inc Recent Developments
10.16 Tissue Genesis
10.16.1 Tissue Genesis Company Information, Head Office, Market Area, and Industry Position
10.16.2 Tissue Genesis Adipose Tissue Derived Stem Cell Models, Specifications, and Application
10.16.3 Tissue Genesis Adipose Tissue Derived Stem Cell Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Tissue Genesis Company Profile and Main Business
10.16.5 Tissue Genesis Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables and Figures
Table 1. Adipose Tissue Derived Stem Cell Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Adipose Tissue Derived Stem Cell Market Restraints
Table 3. Adipose Tissue Derived Stem Cell Market Trends
Table 4. Adipose Tissue Derived Stem Cell Industry Policy
Table 5. Global Adipose Tissue Derived Stem Cell Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Adipose Tissue Derived Stem Cell Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Adipose Tissue Derived Stem Cell Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Adipose Tissue Derived Stem Cell Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Adipose Tissue Derived Stem Cell Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Adipose Tissue Derived Stem Cell Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Adipose Tissue Derived Stem Cell Mergers & Acquisitions, Expansion Plans
Table 12. Global Adipose Tissue Derived Stem Cell Manufacturers Product Type
Table 13. Head Office and Adipose Tissue Derived Stem Cell Production Site of Key Manufacturer
Table 14. Adipose Tissue Derived Stem Cell Capacity of Major Manufacturers and Future Plan
Table 15. China Adipose Tissue Derived Stem Cell Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Adipose Tissue Derived Stem Cell Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Adipose Tissue Derived Stem Cell Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Adipose Tissue Derived Stem Cell Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Adipose Tissue Derived Stem Cell Production by Region, 2018-2023, (K Units)
Table 20. Global Adipose Tissue Derived Stem Cell Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Adipose Tissue Derived Stem Cell Upstream (Raw Materials)
Table 22. Global Adipose Tissue Derived Stem Cell Typical Customers
Table 23. Adipose Tissue Derived Stem Cell Typical Distributors
Table 24. By Type, Global Adipose Tissue Derived Stem Cell Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Adipose Tissue Derived Stem Cell Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Adipose Tissue Derived Stem Cell Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Adipose Tissue Derived Stem Cell Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Adipose Tissue Derived Stem Cell Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Adipose Tissue Derived Stem Cell Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Adipose Tissue Derived Stem Cell Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2018-2029
Table 34. Lonza Company Information, Head Office, Market Area, and Industry Position
Table 35. Lonza Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 36. Lonza Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Lonza Company Profile and Main Business
Table 38. Lonza Recent Developments
Table 39. ThermoFisher Scientific Inc Company Information, Head Office, Market Area, and Industry Position
Table 40. ThermoFisher Scientific Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 41. ThermoFisher Scientific Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. ThermoFisher Scientific Inc Company Profile and Main Business
Table 43. ThermoFisher Scientific Inc Recent Developments
Table 44. Celprogen, Inc Company Information, Head Office, Market Area, and Industry Position
Table 45. Celprogen, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 46. Celprogen, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Celprogen, Inc Company Profile and Main Business
Table 48. Celprogen, Inc Recent Developments
Table 49. iXCells Biotechnologies Company Information, Head Office, Market Area, and Industry Position
Table 50. iXCells Biotechnologies Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 51. iXCells Biotechnologies Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. iXCells Biotechnologies Company Profile and Main Business
Table 53. iXCells Biotechnologies Recent Developments
Table 54. Merck KGaA Company Information, Head Office, Market Area, and Industry Position
Table 55. Merck KGaA Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 56. Merck KGaA Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Merck KGaA Company Profile and Main Business
Table 58. Merck KGaA Recent Developments
Table 59. Lifeline Cell Technology Company Information, Head Office, Market Area, and Industry Position
Table 60. Lifeline Cell Technology Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 61. Lifeline Cell Technology Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Lifeline Cell Technology Company Profile and Main Business
Table 63. Lifeline Cell Technology Recent Developments
Table 64. AlloCure, Inc Company Information, Head Office, Market Area, and Industry Position
Table 65. AlloCure, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 66. AlloCure, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. AlloCure, Inc Company Profile and Main Business
Table 68. AlloCure, Inc Recent Developments
Table 69. Antria, Inc Company Information, Head Office, Market Area, and Industry Position
Table 70. Antria, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 71. Antria, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Antria, Inc Company Profile and Main Business
Table 73. Antria, Inc Recent Developments
Table 74. Celgene Corporation Company Information, Head Office, Market Area, and Industry Position
Table 75. Celgene Corporation Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 76. Celgene Corporation Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Celgene Corporation Company Profile and Main Business
Table 78. Celgene Corporation Recent Developments
Table 79. Cellleris SA Company Information, Head Office, Market Area, and Industry Position
Table 80. Cellleris SA Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 81. Cellleris SA Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Cellleris SA Company Profile and Main Business
Table 83. Cellleris SA Recent Developments
Table 84. Corestem, Inc Company Information, Head Office, Market Area, and Industry Position
Table 85. Corestem, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 86. Corestem, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Corestem, Inc Company Profile and Main Business
Table 88. Corestem, Inc Recent Developments
Table 89. Cytori Therapeutics, Inc Company Information, Head Office, Market Area, and Industry Position
Table 90. Cytori Therapeutics, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 91. Cytori Therapeutics, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Cytori Therapeutics, Inc Company Profile and Main Business
Table 93. Cytori Therapeutics, Inc Recent Developments
Table 94. Intrexon, Inc Company Information, Head Office, Market Area, and Industry Position
Table 95. Intrexon, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 96. Intrexon, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Intrexon, Inc Company Profile and Main Business
Table 98. Intrexon, Inc Recent Developments
Table 99. Mesoblast Ltd Company Information, Head Office, Market Area, and Industry Position
Table 100. Mesoblast Ltd Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 101. Mesoblast Ltd Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Mesoblast Ltd Company Profile and Main Business
Table 103. Mesoblast Ltd Recent Developments
Table 104. Pluristem Therapeutics, Inc Company Information, Head Office, Market Area, and Industry Position
Table 105. Pluristem Therapeutics, Inc Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 106. Pluristem Therapeutics, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Pluristem Therapeutics, Inc Company Profile and Main Business
Table 108. Pluristem Therapeutics, Inc Recent Developments
Table 109. Tissue Genesis Company Information, Head Office, Market Area, and Industry Position
Table 110. Tissue Genesis Adipose Tissue Derived Stem Cell Models, Specifications, and Application
Table 111. Tissue Genesis Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Tissue Genesis Company Profile and Main Business
Table 113. Tissue Genesis Recent Developments
List of Figures
Figure 1. Adipose Tissue Derived Stem Cell Picture
Figure 2. Global Adipose Tissue Derived Stem Cell Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Adipose Tissue Derived Stem Cell Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Adipose Tissue Derived Stem Cell Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Adipose Tissue Derived Stem Cell Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Adipose Tissue Derived Stem Cell Sales Quantity (K Units) & (2018-2029)
Figure 7. China Adipose Tissue Derived Stem Cell Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Adipose Tissue Derived Stem Cell Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Adipose Tissue Derived Stem Cell Market Share of Global, 2018-2029
Figure 10. Global Adipose Tissue Derived Stem Cell Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Adipose Tissue Derived Stem Cell Key Participants, Market Share, 2022
Figure 12. Global Adipose Tissue Derived Stem Cell Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Adipose Tissue Derived Stem Cell Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Adipose Tissue Derived Stem Cell Production Market Share & Forecast by Region, 2018-2029
Figure 15. Adipose Tissue Derived Stem Cell Industry Chain
Figure 16. Adipose Tissue Derived Stem Cell Procurement Model
Figure 17. Adipose Tissue Derived Stem Cell Sales Model
Figure 18. Adipose Tissue Derived Stem Cell Sales Channels, Direct Sales, and Distribution
Figure 19. Source of Human Fat
Figure 20. Source of Animal Fat
Figure 21. By Type, Global Adipose Tissue Derived Stem Cell Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Adipose Tissue Derived Stem Cell Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Adipose Tissue Derived Stem Cell Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Regenerative Medicine
Figure 27. Plastic Surgery
Figure 28. Other
Figure 29. By Application, Global Adipose Tissue Derived Stem Cell Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Adipose Tissue Derived Stem Cell Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Adipose Tissue Derived Stem Cell Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Adipose Tissue Derived Stem Cell Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2018-2029
Figure 36. North America Adipose Tissue Derived Stem Cell Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Adipose Tissue Derived Stem Cell Consumption Value Market Share, 2022
Figure 38. Europe Adipose Tissue Derived Stem Cell Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Adipose Tissue Derived Stem Cell Consumption Value Market Share, 2022
Figure 40. Asia Pacific Adipose Tissue Derived Stem Cell Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Adipose Tissue Derived Stem Cell Consumption Value Market Share, 2022
Figure 42. South America Adipose Tissue Derived Stem Cell Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Adipose Tissue Derived Stem Cell Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Adipose Tissue Derived Stem Cell Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Reason to Buy
- Current and future of Uncategorized Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Uncategorized Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Uncategorized Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Uncategorized Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets